首页> 外国专利> Imidazole derivatives as blockers of receptor, n-methyl-d-aspartate

Imidazole derivatives as blockers of receptor, n-methyl-d-aspartate

机译:咪唑衍生物作为受体阻滞剂,n-甲基-d-天冬氨酸

摘要

Refers to imidazole Derivatives of formula I where is phenyl, pyridin-2-yl, pyridin-3-yl) piperidin-1-yl; R1 and R2 are h, halogen, alkyl, cycloalkyl, alquenilo, trifluoromethyl,- or trifluoromethyl, among others; R3 is H, alkyl, cycloalkyl, phenyl, alkyl, amino, among others; R4 and R5 are h, alkyl or next to C form (CH2) 4; R6 and r6 'is H, alkyl; X is n, c = and = N,NH, n = CH, CH = N; Z is nr7 CR7 =, =, =, N CR7, among others; CH2OH R7 is H, alkyl; n is 0 - 2; M is 0 to 1.Preferred compounds are 1h imidazole, 1 - [1 - (4 - chlorine - 3-methylphenyl) - 1H imidazole - 4-yl] methyl] - 2 - Ethyl; 1h imidazole, 1 [[1 - (4 - chlorine - 3-methylphenyl) - 1H imidazole - 4 - il] methyl] - 2 - methyl - 1 - (3,4 - Dichloro phenyl) - 3 - (2 - methyl - imidazol-1-yl - methyl) - 1H pyrazole, among others. It also relates to a process for Preparation.The compounds are specific blockers of receptor subtype n-methyl-d-aspartate (NMDA) and may be useful for the treatment of Neurodegenerative Diseases, Alzheimer's disease, Parkinson's disease,Huntington's disease, Amyotrophic lateral sclerosis, neurodegeneration associated with viral and bacterial infections, depression
机译:指式I的咪唑衍生物,其中为苯基,吡啶-2-基,吡啶-3-基)哌啶-1-基; R1和R2为h,卤素,烷基,环烷基,alquenilo,三氟甲基,-或三氟甲基等。 R 3是H,烷基,环烷基,苯基,烷基,氨基,等等。 R4和R5是h,烷基或C形式(CH2)4的邻位; R6和r6'是H,烷基; X为n,c =且= N,NH,n = CH,CH = N; Z是nr7 CR7 =,=,=,N CR7等; CH 2 OH R 7为H,烷基; n是0-2; M为0至1。优选的化合物为1h咪唑,1- [1-(4-氯-3-甲基苯基)-1H咪唑-4-基]甲基] -2-乙基; 1h咪唑,1 [[[1-(4--氯-3-甲基苯基)-1H咪唑-4-il]甲基]-2-甲基-1-(3,4-二氯苯基)-3-(2-甲基-咪唑-1-基-甲基)-1H吡唑等。该化合物还涉及制备方法。该化合物是受体亚型n-甲基-d-天冬氨酸(NMDA)的特异性阻滞剂,可用于治疗神经退行性疾病,阿尔茨海默氏病,帕金森氏病,亨廷顿氏病,肌萎缩性侧索硬化症,与病毒和细菌感染有关的神经变性,抑郁

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号